HK2 and neoplasm: In the study conducted by Sun et al., the co-administration of HK II inhibitors such as 2-DG or 3-BrPA augmented the sensitivity of tumor cells to BCNU when compared to the usage of chloroethylnitrosoureas (CENUs) alone [118,119,120].